Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Foundation to Support Cell Transplant Research Launches Official Informational Web Site

By LabMedica International staff writers
Posted on 30 Apr 2009
A new Internet presence has been initiated that has been designed to increase awareness and further funding for stem cell transplant research.

The U.S. More...
National Foundation to Support Cell Transplant Research (NFCTR; Louisville, KY, USA) has launched its official web site to promote and support adult stem cell transplant research. Founded in late 2005, the NFCTR promotes and funds peer-reviewed research and early stage clinical trials in the field of adult stem cell research. By supporting both collaboration and information-sharing in a number of strong academic settings, the NFCTR works to create networking opportunities that readily utilize and expedite the science.

The NFCTR believes that funding ground-breaking research in multiple qualified institutions has unlimited potential to further the field of adult stem cell transplantation and develop new treatments for a large number of diseases and conditions affecting people worldwide. "The potential for curative therapies afforded by adult stem cell research is extremely promising," stated Dr. Paula P. Grisanti, cofounder and chairman of the NFCTR, "and we are fully committed to supporting and funding this critical research. It is our hope that this new web site will help to increase public awareness and generate the support required to fund these important studies."

People worldwide--many of them children or young adults--may benefit from these promising adult stem cell therapies. "This research has far-reaching implications for the treatment of many types of disease," added board of directors member Dennis Riggs. "Success, even at a modest level, may ultimately affect a large number of people on every continent...perhaps a close friend or family member...or maybe even yourself. It touches everyone."

NFCTR was founded by a small group of individuals--each personally impacted by the potential for this critical research. Stem cell research has the potential to revolutionize the treatment of a large number of diseases and conditions affecting people worldwide.

Related Links:
National Foundation to Support Cell Transplant Research



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.